US5447684A
(en)
*
|
1988-10-03 |
1995-09-05 |
Williams; Robert M. |
Sterilization devices, sporicidal compositions, sterilization methods, and devices for reducing surface tension
|
US5540934A
(en)
*
|
1994-06-22 |
1996-07-30 |
Touitou; Elka |
Compositions for applying active substances to or through the skin
|
US20020048596A1
(en)
*
|
1994-12-30 |
2002-04-25 |
Gregor Cevc |
Preparation for the transport of an active substance across barriers
|
DE19517147C2
(de)
*
|
1995-05-10 |
1999-07-01 |
Hexal Pharmaforschung Gmbh |
Aciclovir-Zubereitung
|
AU2036297A
(en)
*
|
1996-03-20 |
1997-10-10 |
Glaxo Group Limited |
Topical formulations of aciclovir
|
US5834016A
(en)
*
|
1996-04-04 |
1998-11-10 |
Cilag Ag |
Liposome-based topical vitamin D formulation
|
EP0914159A1
(de)
*
|
1996-07-13 |
1999-05-12 |
ratiopharm GmbH |
Topische phospholipidhaltige aciclovirzubereitung
|
GB9618974D0
(en)
*
|
1996-09-11 |
1996-10-23 |
Glaxo Group Ltd |
Medicaments
|
US6495579B1
(en)
|
1996-12-02 |
2002-12-17 |
Angiotech Pharmaceuticals, Inc. |
Method for treating multiple sclerosis
|
US6515016B2
(en)
*
|
1996-12-02 |
2003-02-04 |
Angiotech Pharmaceuticals, Inc. |
Composition and methods of paclitaxel for treating psoriasis
|
AU5777498A
(en)
*
|
1997-01-13 |
1998-08-03 |
Cilag A.G. |
Liposome-based topical tretinoin formulation
|
US6113940A
(en)
*
|
1997-03-03 |
2000-09-05 |
Brooke; Lawrence L. |
Cannabinoid patch and method for cannabis transdermal delivery
|
US6132762A
(en)
*
|
1997-05-05 |
2000-10-17 |
Cristobal; Walter |
Transcutaneous application of marijuana
|
US20040131579A1
(en)
*
|
1998-09-10 |
2004-07-08 |
Avon Products, Inc. |
Method and compositions for reducing dermatological aging and for reducing bruising
|
AU770803B2
(en)
|
1998-12-23 |
2004-03-04 |
Idea Ag |
Improved formulation for topical non-invasive application in vivo
|
SI1031346T1
(en)
|
1999-01-27 |
2002-08-31 |
Idea Ag |
Noninvasive vaccination through the skin
|
PT1031347E
(pt)
|
1999-01-27 |
2002-09-30 |
Idea Ag |
Transporte/imunizacao transnasal com veiculos muitissimo adaptaveis
|
GB9902527D0
(en)
*
|
1999-02-04 |
1999-03-24 |
Phares Pharm Res Nv |
Compositions
|
US6491929B1
(en)
*
|
1999-03-01 |
2002-12-10 |
The General Hospital Corporation |
Skin cosmetics
|
AU5409699A
(en)
*
|
1999-07-05 |
2001-01-22 |
Idea Ag |
A method for the improvement of transport across adaptable semi-permeable barriers
|
CA2341035A1
(en)
*
|
1999-07-08 |
2001-01-18 |
Orlando Hung |
Pulmonary delivery of liposomal-encapsulated cannabinoids
|
KR20020020274A
(ko)
*
|
1999-08-18 |
2002-03-14 |
히라타 다다시 |
육모제
|
US6747058B1
(en)
*
|
1999-08-20 |
2004-06-08 |
Unimed Pharmaceuticals, Inc. |
Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor
|
US7648696B2
(en)
*
|
1999-08-20 |
2010-01-19 |
Unimed Pharmaceuticals, Llc |
Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent
|
US8173709B2
(en)
*
|
1999-09-22 |
2012-05-08 |
Quadex Pharmaceuticals, Llc |
Anti-infective methods for treating pathogen-induced disordered tissues
|
US6211243B1
(en)
*
|
1999-09-22 |
2001-04-03 |
B. Ron Johnson |
Methods for treating cold sores with anti-infective compositions
|
EP1138313A1
(de)
*
|
2000-03-28 |
2001-10-04 |
Primacare S.A. |
Pro-liposomen
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
US20070225379A1
(en)
*
|
2001-08-03 |
2007-09-27 |
Carrara Dario Norberto R |
Transdermal delivery of systemically active central nervous system drugs
|
AU2001282064B2
(en)
|
2000-08-03 |
2007-02-01 |
Antares Pharma Ipl Ag |
Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
US7442369B1
(en)
*
|
2000-08-09 |
2008-10-28 |
Mcneil Ab |
Compositions of minoxidil
|
US20040092494A9
(en)
*
|
2000-08-30 |
2004-05-13 |
Dudley Robert E. |
Method of increasing testosterone and related steroid concentrations in women
|
US20040002482A1
(en)
*
|
2000-08-30 |
2004-01-01 |
Dudley Robert E. |
Androgen pharmaceutical composition and method for treating depression
|
US6503894B1
(en)
*
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
US10004684B2
(en)
|
2001-02-14 |
2018-06-26 |
Gw Pharma Limited |
Pharmaceutical formulations
|
JP4467883B2
(ja)
|
2001-02-14 |
2010-05-26 |
ジーダブリュー・ファーマ・リミテッド |
医薬製剤
|
EP1411897A4
(en)
*
|
2001-06-26 |
2010-08-11 |
Yissum Res Dev Co |
COMPOSITIONS AND METHODS FOR INTRA-CELLULAR DELIVERY
|
PL371626A1
(en)
*
|
2002-01-21 |
2005-06-27 |
Vasogen Ireland Limited |
Pharmaceutically acceptable phosphate-glycerol carrying bodies
|
DE10203923B4
(de)
*
|
2002-01-31 |
2011-06-01 |
Klinipharm Gmbh |
Verfahren zur Erhöhung der Wasserlöslichkeit lipophiler Wirkstoffe, Herstellung von hochkonzentrierten wässrigen Zusammensetzungen dieser Wirkstoffe, derartige Produkte und ihre Verwendung
|
US20040033253A1
(en)
*
|
2002-02-19 |
2004-02-19 |
Ihor Shevchuk |
Acyl opioid antagonists
|
US7105173B1
(en)
|
2002-03-21 |
2006-09-12 |
Rolling Kenneth J |
Nicotine replacement applique
|
AU2003251482A1
(en)
|
2002-06-10 |
2003-12-22 |
Euro-Celtique, S.A. |
Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein
|
US20030235610A1
(en)
*
|
2002-06-21 |
2003-12-25 |
Piedmont Pharmaceuticals, Llc |
Liposomes containing biologically active compounds
|
AU2003268144A1
(en)
*
|
2002-08-20 |
2004-03-11 |
Euro-Celtique, S.A. |
Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist
|
KR100489701B1
(ko)
*
|
2002-10-09 |
2005-05-16 |
주식회사 태평양 |
고농도의 트리터페노이드를 함유하는 미소화 리포좀 및 그제조방법
|
US20040105881A1
(en)
*
|
2002-10-11 |
2004-06-03 |
Gregor Cevc |
Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
|
US20040224010A1
(en)
*
|
2002-11-15 |
2004-11-11 |
Optime Therapeutics, Inc. |
Ophthalmic liposome compositions and uses thereof
|
ES2301886T3
(es)
*
|
2002-12-20 |
2008-07-01 |
Idexx Laboratories, Inc. |
Formulacion analgesica liposomal que comprende diclofenac y su uso para tratamiento de caballos.
|
DE602004016292D1
(de)
*
|
2003-01-20 |
2008-10-16 |
Auriga Internat S A |
Verwendung einer zusammensetzung mit vitamin k1-oxid oder einem derivat daraus zur behandlung und/oder vorbeugung von hautverletzungen bei säugern
|
DE10308852A1
(de)
*
|
2003-02-27 |
2004-09-09 |
Rovi Gmbh & Co. Kosmetische Rohstoffe Kg |
Mittel gegen Faltenbildung der Haut
|
US20080020028A1
(en)
*
|
2003-08-20 |
2008-01-24 |
Euro-Celtique S.A. |
Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
|
NZ546106A
(en)
*
|
2003-10-10 |
2008-10-31 |
Antares Pharma Ipl Ag |
Transdermal pharmaceutical formulation for minimizing skin residues
|
SE0400235D0
(sv)
*
|
2004-02-06 |
2004-02-06 |
Active Biotech Ab |
New composition containing quinoline compounds
|
US8314124B2
(en)
*
|
2004-02-06 |
2012-11-20 |
Active Biotech Ab |
Crystalline salts of quinoline compounds and methods for preparing them
|
EP1757270A1
(en)
*
|
2004-04-02 |
2007-02-28 |
Italfarmaco, S.A. |
Liposomal formulations
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
US8022051B2
(en)
|
2004-10-20 |
2011-09-20 |
Doosan Corporation |
Composition for protection and improvement of skin, or reinforcing skin barrier function comprising phosphatidylserine
|
JP2008519784A
(ja)
*
|
2004-11-12 |
2008-06-12 |
イデア アクチェンゲゼルシャフト |
皮膚状態の治療における拡張表面凝集体
|
US8808715B1
(en)
|
2004-11-23 |
2014-08-19 |
Georgia Regents Research Institute, Inc |
Methods and compositions for modulating keratinocyte function
|
WO2006083373A2
(en)
*
|
2004-11-23 |
2006-08-10 |
Medical College Of Georgia |
Methods and compositions for modulating keratinocyte function
|
CN102008729A
(zh)
*
|
2005-01-07 |
2011-04-13 |
日本乐敦制药株式会社 |
外用组合物
|
US20070088012A1
(en)
*
|
2005-04-08 |
2007-04-19 |
Woun Seo |
Method of treating or preventing type-2 diabetes
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
ES2385513T3
(es)
*
|
2005-10-11 |
2012-07-26 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Composición para administración nasal
|
US8911751B2
(en)
*
|
2005-10-11 |
2014-12-16 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions for nasal delivery
|
BRPI0617294B8
(pt)
|
2005-10-12 |
2021-05-25 |
Besins Healthcare Lu Sarl |
composição farmacêutica em gel hidroalcóolico e uso de testosterona
|
ES2523762T3
(es)
*
|
2005-10-19 |
2014-12-01 |
Teva Pharmaceutical Industries Ltd |
Cristales de laquinimod sódico, y procedimientos para su fabricación
|
WO2008005045A2
(en)
*
|
2005-12-30 |
2008-01-10 |
Dermazone Solutions, Inc. |
Nanolipidic particles
|
US20140271782A1
(en)
|
2013-03-15 |
2014-09-18 |
Dermazone Solutions, Inc. |
Method for preparing nanolipids with encapsulated alcohol
|
CA2646667C
(en)
|
2006-04-21 |
2014-03-11 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
RS52169B
(en)
|
2006-06-12 |
2012-08-31 |
Teva Pharmaceutical Industries Limited |
STABLE LAKVINIMOD PREPARATIONS
|
WO2008036979A2
(en)
*
|
2006-09-22 |
2008-03-27 |
Guilford F Timothy |
Topical application of melatonin directly or in liposomes for the amelioration of itching and histamine and non-histamine related inflammatory skin changes
|
GB2458228B
(en)
*
|
2006-10-12 |
2011-02-23 |
Rohto Pharma |
External preparation for skin
|
WO2008067991A2
(en)
*
|
2006-12-08 |
2008-06-12 |
Antares Pharma Ipl Ag |
Skin-friendly drug complexes for transdermal administration
|
EP2124907B1
(en)
|
2007-03-19 |
2018-05-30 |
Vita Sciences, Llc |
Transdermal patch and method for delivery of vitamin b12
|
PL2682120T3
(pl)
|
2007-12-20 |
2017-02-28 |
Teva Pharmaceutical Industries, Ltd. |
Stabilne preparaty lakwinimodu
|
ES2633658T3
(es)
*
|
2008-09-03 |
2017-09-22 |
Teva Pharmaceutical Industries Ltd. |
Moduladores 2-oxo-1,2-dihidro-quinolina de la función inmunitaria
|
CA2737025C
(en)
*
|
2008-09-27 |
2012-09-04 |
Jina Pharmaceuticals, Inc. |
Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof
|
WO2010086725A1
(en)
*
|
2009-01-30 |
2010-08-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd |
Compositions for nail and skin treatment
|
WO2010086727A1
(en)
*
|
2009-01-30 |
2010-08-05 |
Galderma Pharma Sa |
Stable compositions for nail onychomycosis treatment
|
IT1398268B1
(it)
|
2009-03-10 |
2013-02-22 |
Prigen Srl |
Glicerosomi e loro impiego in preparazioni farmaceutiche e cosmetiche per uso topico
|
DK2458992T3
(en)
*
|
2009-07-30 |
2016-02-08 |
Teva Pharma |
Treatment of crohn's disease with laquinimod
|
SI2467372T1
(sl)
*
|
2009-08-10 |
2016-09-30 |
Teva Pharmaceutical Industries Ltd. |
Zdravljenje motenj, povezanih z BDNF, z uporabo lakvinimoda
|
FR2950807B1
(fr)
*
|
2009-10-06 |
2012-02-03 |
Lvmh Rech |
Composition cosmetique contenant des liposomes encapsules dans un compose oxazolidin-2-one
|
EP2496263B1
(en)
|
2009-11-03 |
2021-12-29 |
Lipidor AB |
Lipid layer forming composition for administration onto a surface of a living organism
|
WO2011064769A1
(en)
|
2009-11-24 |
2011-06-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and pharmaceutical compositions for the treatment of hot flashes
|
US8470833B2
(en)
*
|
2009-12-15 |
2013-06-25 |
Mcneil-Ppc, Inc. |
Hair growth and/or regrowth compositions
|
SG10201501539SA
(en)
*
|
2010-03-03 |
2015-04-29 |
Teva Pharma |
Treatment of lupus arthritis using laquinimod
|
PE20130613A1
(es)
*
|
2010-03-03 |
2013-06-23 |
Teva Pharma |
Tratamiento de lupus nefritis usando laquinimod
|
EP2542079B1
(en)
*
|
2010-03-03 |
2014-05-21 |
Teva Pharmaceutical Industries Ltd. |
Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
|
DE102010013064A1
(de)
|
2010-03-26 |
2011-12-15 |
Gabriele Blume |
Neuartiges Trägersystem für den Transport von Wirkstoffen in die Haut
|
US8846725B2
(en)
|
2011-01-24 |
2014-09-30 |
Quadex Pharmaceuticals, Llc |
Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
|
CN102133183B
(zh)
*
|
2011-03-04 |
2012-02-29 |
湘潭大学 |
一种阿昔洛韦醇质体及其制备方法
|
CN102406605A
(zh)
*
|
2011-04-28 |
2012-04-11 |
辽宁省计划生育科学研究院 |
雄性激素类药物的醇质体制剂及其制备方法
|
JP2014530821A
(ja)
|
2011-10-12 |
2014-11-20 |
テバ ファーマシューティカル インダストリーズ リミティド |
ラキニモドおよびフィンゴリモドを組み合わせた多発性硬化症の治療
|
CN102397255B
(zh)
*
|
2011-11-24 |
2013-06-26 |
广东药学院 |
一种黄体酮醇质体及其制备方法与应用
|
EA201491460A1
(ru)
|
2012-02-03 |
2015-01-30 |
Тева Фармасьютикал Индастриз Лтд. |
ПРИМЕНЕНИЕ ЛАХИНИМОДА В ЛЕЧЕНИИ ПАЦИЕНТОВ С БОЛЕЗНЬЮ КРОНА, У КОТОРЫХ НЕ ЭФФЕКТИВНА ТЕРАПИЯ ПЕРВОЙ ЛИНИИ АНТИ-TNFα
|
TW201400117A
(zh)
|
2012-06-05 |
2014-01-01 |
Teva Pharma |
使用拉喹莫德治療眼發炎疾病
|
CA2890194A1
(en)
|
2012-11-07 |
2014-05-15 |
Teva Pharmaceutical Industries Ltd. |
Amine salts of laquinimod
|
DE102012025485A1
(de)
|
2012-12-20 |
2014-06-26 |
Gabriele Blume |
Neuartige Vesikel für die topische Anwendung in der Pharmazie und Kosmetik
|
US9125911B2
(en)
|
2013-03-14 |
2015-09-08 |
Quadex Pharmaceuticals, Llc |
Combined systemic and topical treatment of disordered tissues
|
US9463180B2
(en)
|
2013-03-14 |
2016-10-11 |
Quadex Pharmaceuticals, Llc |
Treatment of molluscum contagiosum
|
US9549930B2
(en)
|
2013-03-14 |
2017-01-24 |
Quadex Pharmaceuticals, Llc |
Combined systemic and topical treatment of disordered and/or prodromal stage tissue
|
JP2016513711A
(ja)
*
|
2013-03-15 |
2016-05-16 |
リーディング エッジ イノヴェイションズ、エルエルシーLeading Edge Innovations, Llc |
高レベルの水混和性溶媒を含有する、疎水性物質の実質的に界面活性剤を含まないサブミクロン分散液
|
US20140322428A1
(en)
|
2013-03-15 |
2014-10-30 |
Leading Edge Innovations, LLC |
Compositions having an oil-in-water dispersion of submicron particles to enhance foods and beverages
|
WO2014184173A1
(en)
*
|
2013-05-14 |
2014-11-20 |
Montero Gida Sanayi Ve Ticaret A.S. |
Hair care formulations
|
TWM473835U
(zh)
*
|
2013-05-15 |
2014-03-11 |
Wu xu sheng |
微米牛樟芝微脂載體結構
|
US20170172922A1
(en)
*
|
2013-05-15 |
2017-06-22 |
Hsu-Shen WU |
Micron taiwanofungus camphoratus liposome structure
|
AU2014311225B2
(en)
|
2013-08-30 |
2019-12-19 |
Dalhousie University |
Compositions and methods for the removal of tattoos
|
US20150147382A1
(en)
*
|
2013-09-23 |
2015-05-28 |
Exir Nano Sina Company |
Topical liposomal compositions for delivering hydrophobic drugs and methods preparing same
|
WO2015123750A1
(en)
*
|
2014-02-20 |
2015-08-27 |
Cura Health Inc. |
Transdermal composition for treating pain
|
CN106573014A
(zh)
|
2014-04-29 |
2017-04-19 |
梯瓦制药工业有限公司 |
用于治疗具有高残疾状况的复发‑缓解型多发性硬化症(rrms)的患者的拉喹莫德
|
US10987048B2
(en)
|
2014-08-13 |
2021-04-27 |
Elwha Llc |
Systems, methods, and devices to incentivize inhaler use
|
US10245393B2
(en)
|
2014-08-13 |
2019-04-02 |
Elwha Llc |
Methods, systems, and devices related to a supplemental inhaler
|
US10765817B2
(en)
|
2014-08-13 |
2020-09-08 |
Elwha, Llc |
Methods, systems, and devices related to delivery of alcohol with an inhaler
|
US10028904B2
(en)
|
2014-12-04 |
2018-07-24 |
Wisconsin Alumni Research Foundation |
Transdermal cannabinoid formulations
|
US9375417B2
(en)
|
2014-12-04 |
2016-06-28 |
Mary's Medicinals LLC |
Transdermal cannabinoid formulations
|
TWM513697U
(zh)
*
|
2015-06-26 |
2015-12-11 |
Ma Shen Kai Ruei Co Ltd |
仿生物間質系統的載體結構
|
CN105380905A
(zh)
*
|
2015-12-17 |
2016-03-09 |
重庆医科大学附属永川医院 |
一种sod醇质体及其制备方法
|
US11147777B1
(en)
|
2017-06-16 |
2021-10-19 |
Charlotte's Web, Inc. |
Methods and formulations for efficacious pain relief by transdermal delivery of cannabidiol
|
KR101810160B1
(ko)
*
|
2017-06-30 |
2018-01-25 |
주식회사 셀리제코스메틱 |
생리활성물질이 봉입된 에토좀 제조 방법, 에토좀 조성물 및 에토좀 조성물을 포함하는 화장료 조성물
|
WO2019087084A1
(en)
|
2017-11-02 |
2019-05-09 |
Eman Biodiscoveries Sd. Bhd. |
Extract of orthosiphon stamineus, formulations, and uses thereof
|
US20200078316A1
(en)
|
2018-09-06 |
2020-03-12 |
NuVessl, Inc. |
Method of Using Cannabinoids Encapsulated in Phospholipid Carriers for Transmucosal and Transdermal Administration
|
US20200188298A1
(en)
|
2018-12-14 |
2020-06-18 |
NuVessl, Inc. |
Method For Using Composition With Enhanced Passenger Molecule Loading
|
US20200345609A1
(en)
*
|
2019-04-30 |
2020-11-05 |
L'oreal |
Photostable antioxidant cosmetic composition
|
CN110664806B
(zh)
*
|
2019-10-17 |
2023-02-28 |
广东省农业科学院动物卫生研究所 |
一种非泼罗尼与甲氧普烯二元醇质体及其制备方法和应用
|
CN115737561A
(zh)
*
|
2022-09-16 |
2023-03-07 |
北京市中医药研究所 |
复方二元醇质体、其制备方法及应用
|